COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

31,704 Articles (22,913 medRxiv, 8,791 bioRxiv)

Most recent first Previous |  Page 1637: Articles 16361-16370  | Next

Real World Effectiveness of COVID-19 mRNA Vaccines against Hospitalizations and Deaths in the United States
Vahidy, F. S., Pischel, L., Tano, M. E., Pan, A. P., Boom, M. L., Sostman, H. D., Nasir, K., Omer, S. B.
10.1101/2021.04.21.21255873 — Posted: 2021-04-23 Discussion: Onsite
Impact of vaccination on SARS-CoV-2 cases in the community: a population-based study using the UK COVID-19 Infection Survey
Pritchard, E., Matthews, P., Stoesser, N., Eyre, D., Gethings, O., Vitha, K.-D., Jones, J., House, T., VanSteenhouse, H., Bell, I., Bell, J., Newton, J., Farrar, J., Diamond, I., Rourke, E., Studley, R., Crook, D. W., peto, t. E., Walker, A. S., Pouwels, K. B., Coronavirus Infection Survey team
10.1101/2021.04.22.21255913 — Posted: 2021-04-23 Discussion: Onsite
The impact of SARS-CoV-2 vaccines on antibody responses in the general population in the United Kingdom
Wei, J., Stoesser, N., Matthews, P. C., Studley, R., Bell, I., Bell, J. I., Newton, J. N., Farrar, J., Diamond, I., Rourke, E., Howarth, A., Marsden, B. D., Hoosdally, S., Jones, E. Y., Stuart, D. I., Crook, D. W., Peto, T. E., Pouwels, K. B., Eyre, D. W., Walker, A. S., COVID-19 Infection Survey team
10.1101/2021.04.22.21255911 — Posted: 2021-04-23
Addressing racial/ethnic disparities in the COVID-19 vaccination campaign
Reitsma, M. B., Goldhaber-Fiebert, J. D., Salomon, J. A.
10.1101/2021.04.21.21255878 — Posted: 2021-04-23
Associations of SARS-CoV-2 serum IgG with occupation and demographics of military personnel
Zell, J., Lucas, C., Klein, J., Iwasaki, A., Slade, M., Liu, J., Wisnewski, A. V., Redlich, C.
10.1101/2021.04.21.21255881 — Posted: 2021-04-23
Socio-demographic and knowledge-related determinants of vitamin D supplementation in the context of the COVID-19 pandemic: assessment of an educational intervention
Zmitek, K., Hribar, M., Lavrisa, Z., Hristov, H., Kusar, A., Pravst, I.
10.1101/2021.04.21.21255553 — Posted: 2021-04-23
Emotional symptoms, mental fatigue and behavioral adherence after 72 continuous days of strict lockdown during the COVID-19 pandemic in Argentina
Torrente, F., Yoris, A. E., Low, D. M., Lopez, P., Bekinschtein, P., Vazquez, G., Manes, F., Cetkovich, M.
10.1101/2021.04.21.21255866 — Posted: 2021-04-23
Effect of asymptomatic transmission and emergence time on multi-strain viral disease severity
Alizad-Rahvar, A. R., Sadeghi, M.
10.1101/2021.04.18.21255684 — Posted: 2021-04-23
Rapid induction of antigen-specific CD4+ T cells guides coordinated humoral and cellular immune responses to SARS-CoV-2 mRNA vaccination
Painter, M. M., Mathew, D., Goel, R. R., Apostolidis, S. A., Pattekar, A., Kuthuru, O., Baxter, A. E., Herati, R. S., Oldridge, D. A., Gouma, S., Hicks, P., Dysinger, S., Lundgreen, K. A., Kuri-Cervantes, L., Adamski, S., Hicks, A., Korte, S., Giles, J. R., Weirick, M. E., McAllister, C. M., Dougherty, J., Long, S., D'Andrea, K., Hamilton, J. T., Betts, M. R., Bates, P., Hensley, S. E., Grifoni, A., Weiskopf, D., Sette, A., Greenplate, A. R., Wherry, E. J.
10.1101/2021.04.21.440862 — Posted: 2021-04-22 Discussion: Onsite
Amino acids 484 and 494 of SARS-CoV-2 spike are hotspots of immune evasion affecting antibody but not ACE2 binding
Alenquer, M., Ferreira, F., Lousa, D., Valerio, M., Medina-Lopes, M., Bergman, M.-L., Goncalves, J., Demengeot, J., Leite, R. B., Lilue, J., Ning, Z., Penha-Goncalves, C., Soares, H., Soares, C., Amorim, M. J.
10.1101/2021.04.22.441007 — Posted: 2021-04-22

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).